睡眠障碍中的蛋白质化修饰:机制和治疗潜力
Xiaoyang Lian1, Xiaojie Li2, Xiaoying Wang1
1Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China.
蛋白质化,一种代谢过程,与睡眠障碍有关. 需要进一步的研究来了解它在人类睡眠调节和相关条件中的作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 睡眠医学 睡眠医学
背景情况:
- 蛋白质化是一种依赖于新陈代谢的翻译后修饰的类别.
- 这些修改越来越被认为是睡眠障碍分子机制的调节成分.
- 不同的乙化类型,包括乙化和脂化,影响睡眠调节中的关键蛋白质.
研究的目的:
- 审查当前对睡眠障碍中蛋白质酸化的机制性见解.
- 强调该领域新兴的概念进步.
- 概述翻译研究的挑战和未来方向.
主要方法:
- 文献综述综合了当前的机械学见解.
- 强调新兴的概念进步.
- 确定关键挑战和未来方向.
主要成果:
- 蛋白质化影响昼夜钟蛋白,神经营养因子,突触分子和线粒体代谢.
- 病理性代谢状态可能导致 site-specific 的化丰富.
- 在临床前模型中,化事件与氧化应激,神经炎症和昼夜干扰有关.
结论:
- 蛋白质化在睡眠障碍的分子机制中起着重要作用.
- 虽然临床前证据越来越多,但强大的人类数据有限.
- 进一步的翻译研究至关重要,以了解化对人类睡眠医学的全部影响.
更多相关视频
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
08:44Electrocorticographic Recording of Cerebral Cortex Areas Manipulated Using an Adeno-Associated Virus Targeting Cofilin in Mice
Published on: February 21, 2021
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Narcolepsy
Phase II Reactions: Acetylation Reactions
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Management of Insomnia
REM Sleep Behavior Disorder
RBD is significantly associated with...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
